Rapidly Progressive Glomerulonephritis (RPGN)
Clinical Subject Page
Also called
ICD-10
Specialty
Onset
Reviewed
-
OverviewOverview
-
Etiology & Risk FactorsEtiology & Risk Factors
-
PathophysiologyPathophysiology
-
Clinical PresentationClinical Presentation
-
History TakingHistory Taking
-
Physical ExaminationPhysical Examination
-
InvestigationsInvestigations
-
DiagnosisDiagnosis
-
ManagementManagement
-
ComplicationsComplications
-
PrognosisPrognosis
-
Key Points / Clinical PearlsKey Points / Clinical Pearls
What is Rapidly Progressive Glomerulonephritis (RPGN)?
-Rapidly Progressive Glomerulonephritis (RPGN) is not a single disease but a syndrome caused by severe glomerular injury.
-The three major types are:
- Type I: Anti-glomerular basement membrane (anti-GBM) disease
- Type II: Immune complex-mediated disease
- Type III: Pauci–immune disease, usually associated with antineutrophil cytoplasmic antibodies (ANCA)
-It typically presents with rapidly worsening kidney function, hematuria, proteinuria, and features of nephritic syndrome.
Etiology & Risk Factors
-Etiology
-Rapidly Progressive Glomerulonephritis (RPGN) is caused by severe glomerular injury due to:
- Anti-GBM antibodies — Type I
- Immune complex deposition — Type II
- ANCA-associated small-vessel vasculitis — Type III
-Risk Factors:
- Autoimmune disease
- ANCA-associated vasculitis
- Systemic lupus erythematosus
- Recent or ongoing infection causing immune complex disease
- Anti-GBM disease
Pathophysiology
Severe immune-mediated glomerular injury → disruption of the glomerular capillary wall → leakage of fibrin and inflammatory mediators into Bowman’s space → crescent formation → rapid destruction of glomeruli → rapid fall in GFR → acute kidney injury → kidney failure
Clinical Presentation
-Symptoms:
- Reduced urine output
- Dark or cola-colored urine
- Hematuria
- Fatigue
- Nausea and vomiting
- Dyspnea
- Peripheral edema
-Signs:
- Hypertension
- Peripheral edema
- Signs of fluid overload
- Features of systemic vasculitis or autoimmune disease
History Taking
-Ask about:
- Duration and rate of decline in urine output
- Gross or microscopic hematuria
- Frothy urine
- Recent infection
- Fever or weight loss
- Skin rash or purpura
- Joint pain
- Sinus or nasal symptoms
- Cough or hemoptysis
- Dyspnea
- Previous autoimmune disease
- Previous kidney disease
Physical Examination
-General Examination
- Blood pressure
- Peripheral edema
- Signs of fluid overload
- Pallor when clinically relevant
-System-Specific Examination:
- Skin for purpura or rash
- Respiratory system for pulmonary hemorrhage or edema
- ENT examination for features of granulomatosis with polyangiitis
- Joints and other systems for systemic vasculitis
Investigations
-Complete Blood Count
Relevant for assessing:
-
Anemia
-
Infection
-
Eosinophilia when an alternative diagnosis is suspected
Biochemistry / Specific Tests
-
Serum creatinine and eGFR
-
Serum urea
-
Serum potassium
-
Serum bicarbonate
-
Urinalysis
-
Urine microscopy for dysmorphic red cells and red cell casts
-
Urine protein quantification
Cause-specific tests:
-
ANCA
-
Anti-GBM antibodies
-
Complement levels
-
Antinuclear antibodies and anti-double-stranded DNA when lupus is suspected
-
Infection-related testing when indicated
-Imaging
Renal ultrasound is useful to assess kidney size and exclude urinary obstruction.
-Chest imaging is indicated when pulmonary hemorrhage or pulmonary involvement is suspected.
-Special / Confirmatory Tests
Kidney biopsy is the definitive investigation when clinically feasible and should not be unnecessarily delayed.
Typical findings include:
-
Crescent formation involving glomeruli
-
Linear immunoglobulin deposition in anti-GBM disease
-
Granular immune deposits in immune complex disease
-
Minimal or absent immune deposits in pauci-immune disease
Diagnosis
Rapidly Progressive Glomerulonephritis (RPGN) should be suspected in a patient with:
- Rapid decline in kidney function over days to weeks
- Hematuria
- Active urinary sediment, especially red cell casts
- Variable proteinuria
- Features of nephritic syndrome
Management
1. First-Line / Emergency Management
Rapidly Progressive Glomerulonephritis (RPGN) requires urgent nephrology management.
Immediate management may include:
-
High-dose glucocorticoids when severe immune-mediated disease is strongly suspected
-
Urgent treatment of hyperkalemia
-
Management of pulmonary edema and fluid overload
-
Correction of severe metabolic acidosis
-
Dialysis when indicated
2. Definitive Treatment
Treatment depends on the underlying cause:
-
ANCA-associated disease: glucocorticoids plus rituximab or cyclophosphamide
-
Anti-GBM disease: glucocorticoids plus cyclophosphamide and plasma exchange
-
Immune complex disease: treat the underlying disease, with immunosuppression when appropriate
3. Medical Treatment
-
High-dose glucocorticoids
-
Rituximab for appropriate ANCA-associated disease
-
Cyclophosphamide for severe immune-mediated disease
-
Cause-specific immunosuppressive therapy
-
Antihypertensive treatment
-
Diuretics for fluid overload when appropriate
4. Surgical / Procedural Treatment
No routine surgical treatment.
Important procedures may include:
-
Plasma exchange for anti-GBM disease and selected severe conditions
-
Dialysis for severe kidney failure or refractory complications
5. Supportive Management
-
Close monitoring of kidney function
-
Monitoring potassium and acid-base status
-
Fluid balance management
-
Avoid nephrotoxic medications
Complications
- Acute kidney injury
- Kidney failure
- Severe hyperkalemia
- Metabolic acidosis
- Pulmonary edema
- Pulmonary hemorrhage
- Uremia
- Chronic Kidney Disease (CKD)
- End-Stage Renal Disease (ESRD)
Prognosis
-The prognosis of Rapidly Progressive Glomerulonephritis (RPGN) depends on the underlying cause, severity at presentation, degree of crescent formation, baseline kidney function, and speed of treatment.
-Early diagnosis and urgent treatment can preserve kidney function, whereas delayed treatment may result in irreversible kidney failure.
Key Points / Clinical Pearls
- Rapidly Progressive Glomerulonephritis (RPGN) is a severe syndrome causing rapid kidney function loss.
- It is a nephrological emergency.
- Crescent formation is a characteristic pathological finding.
- The three major types are anti-GBM, immune complex-mediated, and pauci-immune.
- Hematuria and red cell casts are important findings.
- ANCA testing is important for suspected pauci-immune disease.
- Anti-GBM antibody testing is essential when anti-GBM disease is suspected.
- Kidney biopsy is a key diagnostic investigation.
- Treatment depends on the underlying cause.
- High-dose glucocorticoids are commonly used in severe immune-mediated disease.
- Rituximab or cyclophosphamide may be required for ANCA-associated disease.
- Anti-GBM disease usually requires plasma exchange with immunosuppressive therapy.
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1-S276. KDIGO .
- Kidney Disease: Improving Global Outcomes (KDIGO) Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. KDIGO .
- Jennette JC, Nachman PH. ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol. 2017;12(4):601-611. Clinical Journal of the American Society of Nephrology .
- Kallenberg CGM. Rapidly Progressive Glomerulonephritis. Clin Kidney J. 2009;2(4):223-229. Clinical Kidney Journal .
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Glomerular Diseases . National Institutes of Health.
- National Library of Medicine (NIH). Rapidly Progressive Glomerulonephritis . StatPearls.
Practice Rapidly Progressive Glomerulonephritis (RPGN) questions
Lock in what you just read with exam-style MCQs and active-recall flashcards from Saturn Medic.